Commitments and Contingencies (Details Narrative) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 36 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 26, 2019
USD ($)
|
Sep. 13, 2018
USD ($)
|
Sep. 13, 2018
EUR (€)
|
Aug. 12, 2016
USD ($)
|
May 05, 2016
USD ($)
|
May 05, 2016
AUD ($)
|
May 04, 2016
USD ($)
|
Jun. 30, 2012 |
Jun. 30, 2018
USD ($)
|
Dec. 31, 2019
USD ($)
shares
|
Jun. 30, 2019
USD ($)
|
Jun. 30, 2018
USD ($)
|
Dec. 31, 2014
USD ($)
|
|
| Penalty amount | $ 30,000 | ||||||||||||
| Operating lease term | 5 years | ||||||||||||
| Rent expense | $ 28,062 | $ 30,521 | |||||||||||
| Contract cost | 49,854 | ||||||||||||
| Royalties percentage | 2.00% | 2.00% | |||||||||||
| Royalty Agreement Terms [Member] | |||||||||||||
| Operating leases income statement revenue percentage | 2.00% | ||||||||||||
| License Agreement Terms [Member] | |||||||||||||
| Operating leases income statement revenue percentage | 5.00% | ||||||||||||
| New Five-Year Operating Lease Agreement [Member] | |||||||||||||
| Operating lease term | 5 years | 5 years | |||||||||||
| Payments for rent | $ 2,469 | $ 2,325 | |||||||||||
| New Five-Year Operating Lease Agreement [Member] | AUD Currency [Member] | |||||||||||||
| Payments for rent | $ 3,606 | ||||||||||||
| Manufacturing Services Agreement [Member] | Minimum [Member] | |||||||||||||
| Anticipated milestone payment | $ 2,500,000 | ||||||||||||
| Manufacturing Services Agreement [Member] | Maximum [Member] | |||||||||||||
| Anticipated milestone payment | $ 5,000,000 | ||||||||||||
| Amatsigroup Agreement [Member] | |||||||||||||
| Payments description | The Company anticipates that its payments to Amatsigroup under the MSA will range between $2.5 million and $5.0 million over three years, when the finished drug product is manufactured and released for clinical trials. The Company has spent a total of $1,689,146 of costs to date under this contract of which $1,689,146 was expensed in prior years. The MSA shall continue for a term of three years unless extended by mutual agreement in writing. | ||||||||||||
| Contract cost | $ 1,689,146 | $ 1,689,146 | $ 1,689,146 | ||||||||||
| One-Year Collaboration Agreement [Member] | |||||||||||||
| Payment for services | $ 59,508 | ||||||||||||
| One-Year Collaboration Agreement [Member] | Euros [Member] | |||||||||||||
| Payment for services | € | € 52,000 | ||||||||||||
| Two-Year Collaboration Agreement [Member] | |||||||||||||
| Payment for services | $ 45,775 | ||||||||||||
| Two-Year Collaboration Agreement [Member] | Euros [Member] | |||||||||||||
| Payment for services | € | € 40,000 | ||||||||||||
| From 2012 through the 2014 [Member] | |||||||||||||
| Penalty amount | $ 10,000 | 10,000 | |||||||||||
| Regal Consulting, LLC [Member] | |||||||||||||
| Loss contingency amount | $ 400,000 | ||||||||||||
| Stock issued for the services, shares | shares | 60,000 | ||||||||||||
| Foley Shechter [Member] | |||||||||||||
| Legal fees | $ 151,032 | ||||||||||||